BioClinica Launches Websend and Creates Efficiencies for Clinical Trial Imaging Delivery


Company News Release

BioClinica™, Inc., (NASDAQ: BIOC) announced the release of BioClinica WebSend, a system that simplifies and accelerates image collection for clinical studies. WebSend transfers and tracks medical images in real-time, offering fast delivery of image data and enhanced data quality with fewer site queries.
BioClinica WebSend is complemented by BioClinica WebView, a solution for managing the electronic sharing, blinding, tracking, archiving and analysis of medical images for clinical trials worldwide.  

“BioClinica WebSend allows any investigator site or imaging center globally to send all medical images to BioClinica electronically in a secure, regulatory-compliant manner.  Along with BioClinica WebView, WebSend manages the collection and validation of those images,” said Mark L. Weinstein, CEO of BioClinica, Inc.   

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.